PMID: 2438239Jan 1, 1987

CI-922--a novel, potent antiallergic compound--II. Activity in animal models of allergy

International Journal of Immunopharmacology
R L AdolphsonL J Robichaud

Abstract

CI-922 (3,7-dimethoxy-4-phenyl-N-1H-tetrazol-5-yl-4H-furo [3,2-b]indole-2-carboxamide, L-arginine salt) is an effective antiallergic in guinea pig, rat, and canine models. This in vivo activity is attributed to its ability to inhibit inflammatory mediator release following antigen challenge in these species. Antigen-induced anaphylaxis in guinea pigs (collapse), which is mediated predominantly by histamine, was prevented by i.p. drug pretreatment. CI-922 (5 mg/kg, i.v.) reduced i.v. antigen-induced falls in pulmonary compliance in mepyramine-pretreated, anesthetized guinea pigs. By comparison, cromolyn sodium was inactive in both guinea pig models. In rats, CI-922 given immediately before antigen challenge (ID50 of 0.29 mg/kg, i.v.) was effective and twice as potent as cromolyn sodium and twenty times more potent than proxicromil in preventing i.v. antigen-induced pulmonary anaphylaxis. In addition, when the drugs were given 10 min before antigen challenge, only CI-922 caused a dose-related reduction of bronchoconstriction. CI-922 did not show direct antagonist activity when tested against a serotonin-induced bronchospasm, and exhibited only slight activity against a histamine-induced bronchospasm. CI-922 (0.3 mg/kg, i.v.) also...Continue Reading

References

Jan 1, 1976·International Archives of Allergy and Applied Immunology·P W MarshallD P Evans
Jan 1, 1978·International Archives of Allergy and Applied Immunology·R D Krell, L W Chakrin
Sep 1, 1975·British Journal of Pharmacology·J B FarmerA M Woods
Oct 1, 1977·Agents and Actions·J AugsteinP Sheard
Jan 1, 1987·International Journal of Immunopharmacology·L J RobichaudR L Adolphson
Jan 1, 1986·International Archives of Allergy and Applied Immunology·L J RobichaudD O Thueson
Jan 1, 1973·International Archives of Allergy and Applied Immunology·W A Taylor, I M Roitt
Jan 1, 1970·International Archives of Allergy and Applied Immunology·E S Assem, J L Mongar
Aug 1, 1973·The Journal of Allergy and Clinical Immunology·M N BlumenthalR B McHugh
Aug 22, 1970·Life Sciences. Pt. 2: Biochemistry, General and Molecular Biology·I Mota, A Perini
Jun 1, 1967·British Journal of Pharmacology and Chemotherapy·H O Collier, G W James
Jan 1, 1974·International Archives of Allergy and Applied Immunology·G F KesslerW M Gold
Jan 1, 1984·International Archives of Allergy and Applied Immunology·R R Schellenberg, A Foster
Jul 1, 1981·Agents and Actions·A F WeltonR A Salvador
Jul 1, 1980·Proceedings of the National Academy of Sciences of the United States of America·J M DrazenE J Corey
Apr 9, 1982·Science·J W WeissK F Austen
Jul 1, 1981·Agents and Actions·D M RitchieM E Rosenthale

Citations

Jan 1, 1990·Journal of Neurotrauma·L J Robichaud, F W Marcoux
Dec 7, 2019·Beilstein Journal of Organic Chemistry·Hoang Huy DoPeter Langer

Related Concepts

3,7-dimethoxy-4-phenyl-N-(1H-tetrazol-5-yl)-4H-furo-(3,2-b)-indole-2-carboxamide 1-arginate
Anaphylaxis
Metazoa
Ascaris
Azoles
Bronchial Spasm
Cross Reactions
Vicrom
Canis familiaris
Histamine Release

Related Feeds

Anaphylaxis

Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death.

Ascariasis (ASM)

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.

Ascariasis

Ascariasis is a helminthic infection of global distribution with more than 1.4 billion persons infected throughout the world. Here is the latest research.